News

TORONTO, June 30 (LifeSiteNews.com) – With scientists just having announced the mapping of the human genome and the accompanying glimpse into a world of designer babies, the New Reproductive Technology boom has gone into overdrive.

On June 17 details of the first cloned human (animal-human) embryo were released. American Cell Technology (ACT), a leading, private biotechnology company, cloned the human embryo in November using a cell from a man’s leg and a cow’s ovum. The human-animal embryo was allowed to live and develop for twelve days before it was killed.

To deal with the booming number of multiple births thanks to fertility drugs and in vitro fertilization, the Society of Obstetricians and Gynecologists of Canada released the first-ever voluntary guidelines on how Canadian doctors should manage multiples. In the June 27 document they suggest that all women carrying multiples should be offered “selective reduction” (abortion of one or more of the babies) if testing reveals that one of their children in utero is deemed unfit. 

Canadian researchers have transplanted slivers of human ovary tissue into muscles on the back of a mouse, harvested potentially viable eggs from the grafts and matured them in a laboratory so humans can now be the offspring of mice

And finally scientists have announced that they are developing a drug to delay menopause by more than ten years, which would result in women conceiving in their 50s and 60s.

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.